Janux Therapeutics, Inc.
JANX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69 | -$58 | -$63 | -$33 |
| Dep. & Amort. | $2 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $33 | $20 | $17 | $7 |
| Change in WC | $1 | -$7 | $4 | $9 |
| Other Non-Cash | -$11 | -$8 | -$2 | -$0 |
| Operating Cash Flow | -$44 | -$51 | -$43 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$6 | -$1 |
| Net Acquisitions | $0 | $0 | -$65 | $339 |
| Inv. Purchases | -$471 | -$317 | -$294 | -$474 |
| Inv. Sales/Matur. | $213 | $278 | $359 | $134 |
| Other Inv. Act. | $0 | $0 | $65 | -$339 |
| Investing Cash Flow | -$258 | -$41 | $58 | -$341 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $698 | $57 | $1 | $204 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $15 | $3 | $0 | $182 |
| Financing Cash Flow | $713 | $60 | $1 | $387 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $411 | -$32 | $16 | $29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20 | $52 | $36 | $8 |
| End Cash | $431 | $20 | $52 | $36 |
| Free Cash Flow | -$44 | -$52 | -$49 | -$18 |